SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

A Betaville alert and elevated options activity have reignited speculation about a Viking partnership or buyout, with Novo and other large drugmakers frequently floated as potential partners. The deal talk is unconfirmed and debated as rumor-driven trading; traders also point to VK2735s obesity-drug pipeline and ObesityWeek presentations as context.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

A quarterly sales beat and raised outlook, driven by demand for oral Wegovy, are fueling renewed interest in Novo Nordisk. Bulls see the pill rollout as evidence of a growth recovery, while skeptics point to Lilly competition, pricing pressure and weakness in diabetes as unresolved risks.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs abrupt departure as CEO, amid reports of personal-conduct and China-related security scrutiny, has put Nvidias leadership succession at the center of discussion. Traders are divided between speculation that Huang could return or a successor could steady the company and concerns that leadership uncertainty and export-control scrutiny could weigh on the stock; others see the pullback as a buying opportunity ahead of earnings.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Ciscos strong quarterly results and raised full-year outlook have been overshadowed by a sharp post-earnings selloff, with traders focused on lower gross margins from AI hardware mix, slower product-order growth and a next-quarter revenue outlook below the reported quarter. Some call the drop an overreaction and are buying the dip, while others see the margin pressure and growth concerns as reasons for caution.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra shares slid after the CHMP reaffirmed its negative opinion on European authorization for Miplyffa (arimoclomol), with the European Commissions final decision still pending. Traders are split between blaming management and viewing the setback as largely expected, while dip buyers emphasize the drugs U.S. business and the companys cash position.

Flowers Foods, Inc. engages in the production and marketing of packaged bakery foods. It offers breads, buns, rolls, snack items, bagels, English muffins, and tortillas and are sold under a variety of brand names, including Nature’s Own, Dave’s Killer Bread, Wonder, Canyon Bakehouse, Tastykake, and Mrs. Freshley’s. The company was founded by William Howard Flowers, Sr. and Joseph Hampton Flowers, Jr. in 1919 and is headquartered in Thomasville, GA.

Flowers Foods, Inc.

Flowers Foods weak results and lowered outlook, amid persistent volume declines and margin pressure, are driving bearish attention; concern about elevated debt, credit downgrades, and whether the dividend is sustainable is adding to the debate. Some traders see the selloff as excessive and point to the dividend and potential short covering, while others expect further deterioration.

Newsmax Inc. is a holding company, which engages in television broadcasting and multi-platform content publishing that produces original news and editorial content for consumers through various media outlets, including TV new channels, digital and print publications. It operates through the Broadcasting and Digital Segments. The Broadcasting segment produces and licenses news, business news and lifestyle content for distribution through both MVPDs and free OTT streaming platforms. The Digital segment is composed of Newsmax.com and affiliated websites. The company was founded by Christopher Ruddy in 1998 and is headquartered in Boca Raton, FL.

Newsmax Inc. - Ordinary Shares - Class B

Newsmax Inc

Newsmaxs sharp move higher is drawing attention, with traders speculating about a short squeeze and renewed retail momentum. Bulls point to the companys earnings and growth prospects, while skeptics describe the volatility as a possible pump-and-dump; no single new catalyst is clearly established.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned prostate-cancer BLA filing was pushed to mid-2027 amid FDA discussions and assay refinement, prompting a sharp selloff. Traders are split between viewing the delay as a technical manufacturing hurdle that leaves the clinical data intact and worrying it signals execution problems; CEO share sales and a new ATM have intensified concerns about trust and dilution.

Autonomi (ANT) is a cryptocurrency launched in 2025and operates on the Arbitrum platform. Autonomi has a current supply of 1,200,000,000 with 346,331,579 in circulation. The last known price of Autonomi is 0.0311505 USD and is down -0.06 over the last 24 hours. It is currently trading on 15 active market(s) with $124,825.83 traded over the last 24 hours. More information can be found at https://autonomi.com.

Aragon

Most of the attention appears driven by ticker confusion: traders are using ANT.X to discuss Anthropics anticipated IPO, debating its valuation and possible effects on AI and tech stocks. Separate Aragon-related posts mention the projects dissolution and completed token redemption, alongside scattered price speculation.

Modine Manufacturing Co. engages in the provision of thermal management products and solutions. It operates through the Climate Solutions and Performance Technologies business segments. The Climate Solutions segment provides climate-controlled solutions and components, heat transfer products, heating, ventilating, air conditioning and refrigeration products, and data center cooling solutions. The Performance Technologies segment designs and manufactures air- and liquid-cooled technology for vehicular, stationary power, and industrial applications. In addition, the Performance Technologies segment provides thermal solutions to zero-emission and hybrid commercial vehicle and automotive customers, and coating products and application services. The company was founded by Arthur B. Modine on June 23, 1916 and is headquartered in Racine, WI.

Modine Manufacturing Co.

MOD surged on reports that Samsung is discussing an acquisition, though neither a deal nor terms have been confirmed. Traders are debating whether a takeover would justify further upside or whether the reported valuation could leave the stock vulnerable to a pullback, against the backdrop of demand for AI data-center cooling.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CLOV You are buying a hyper-growth company expanding top-line revenue at &gt;50% YoY, generating over $200M in YTD operating cash flow, holding half a billion in liquidity, and scaling an industry-leading AI SaaS division. Once institutional models properly price in the 5-Star tailwinds and Counterpart Health&#39;s software margins, sub-10CLOV will look like history. 🍀📈 $HUM

Joe Dirt Jr

Thibaut

Chris Topher

AnthonyF

Tom Huynh

Ryan Kwasny

Bobby Boucher

Agentic

Michael Hinson

Individual Investor

TyreKicker

Phil

StockTwits for iOS

Clover Health Investments Corp

Humana Inc

 You are buying a hyper-growth company expanding top-line revenue at >50% YoY, generating over $200M in YTD operating cash flow, holding half a billion in liquidity, and scaling an industry-leading AI SaaS division. Once institutional models properly price in the 5-Star tailwinds and Counterpart Health's software margins, sub-10CLOV will look like history. 🍀📈 